RxSight, Inc.RXSTEarnings & Financial Report
Nasdaq · Health Care · Ophthalmic Goods
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| NOS. OF ABOVE PERSONS | 9.90% | 3.9M | ▲ +0.40pp | 2024-11-14 |
| BlackRock, Inc. | 7.00% | 2.8M | flat | 2024-11-08 |
| The Vanguard Group | 5.76% | 2.3M | flat | 2024-11-12 |
| Lord, Abbett & Co. LLC | 5.51% | 2.0M | — | 2024-02-14 |
| Artisan Partners Limited Partnership | 2.90% | 1.2M | ▼ -3.80pp | 2024-11-12 |
| Longitude Capital Partners II, LLC | 2.80% | 994.3K | ▼ -1.60pp | 2023-08-18 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-17 | Ilya Goldshleger | Chief Operating Officer | Option exercise | 12.5K | $4.13 | $51.6K |
| 2026-02-28 | Scott Gaines | Chief Customer Officer | Option exercise | 6.3K | — | — |
| 2026-02-28 | Mark Wilterding | Chief Financial Officer | Option exercise | 20.4K | — | — |
1–3 of 3